Replies to post #2042 on Biotech Values

[rstor1]

+++couldn’t you have made the same argument about IMCL and BMY in 2001?+++

Of course, but my expectation is that things were learned from that example.

Besides, it is not surprising that the prelims were stated this way. Did you look at the p values? I believe that they were aroun 18!!!

I don't follow it closely enough to understand what Genta will be arguing, but it is far form a foregone conclusion that they will get a thumbs-down.

It may be worth a gamble to buy some calls today. They are still expensive, but if they get anything other than an outright rejection, the 12.5's will be in the money, I believe.

Bob